Fig. 2
From: The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
Survival in Study 2 (study at Chiba University Hospital). a Overall survival in PoPH and I/H-PAH (PoPH; n = 11, I/H-PAH: n = 39). There was no significant difference in overall survival between patients with PoPH and patients with I/H-PAH (5-year survival: 79.6% vs. 81.2%, p = 0.64). b Disease-specific survival in PoPH and I/H-PAH (PoPH; n = 11, I/H-PAH; n = 39). There was no significant difference in disease-specific survival between patients with PoPH and patients with I/H-PAH (5-year survival: 79.6% vs. 83.7%, p = 0.93)